| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | Scherle Peggy | Chief Scientific Officer | Aug 26, 2021 | Option Exercise | $1.43 | 1,700 | 2,431 | 174,620 | Aug 30, 2021, 05:16 PM | |
| PRLD | Prelude Therapeutics Inc | Scherle Peggy | Chief Scientific Officer | Aug 26, 2021 | Sale | $35.19 | 1,700 | 59,819 | 172,920 | Aug 30, 2021, 05:16 PM | |
| PRLD | Prelude Therapeutics Inc | Scherle Peggy | Chief Scientific Officer | Aug 27, 2021 | Option Exercise | $1.43 | 6,014 | 8,600 | 178,934 | Aug 30, 2021, 05:16 PM | |
| PRLD | Prelude Therapeutics Inc | Scherle Peggy | Chief Scientific Officer | Aug 27, 2021 | Sale | $35.91 | 6,014 | 215,967 | 176,234 | Aug 30, 2021, 05:16 PM | |
| PRLD | Prelude Therapeutics Inc | Scherle Peggy | Chief Scientific Officer | Aug 13, 2021 | Option Exercise | $1.54 | 2,286 | 3,526 | 175,206 | Aug 17, 2021, 04:44 PM | |
| PRLD | Prelude Therapeutics Inc | Scherle Peggy | Chief Scientific Officer | Aug 13, 2021 | Sale | $35.07 | 2,286 | 80,161 | 172,920 | Aug 17, 2021, 04:44 PM | |
| PRLD | Prelude Therapeutics Inc | Scherle Peggy | Chief Scientific Officer | Jul 27, 2021 | Option Exercise | $1.43 | 20,000 | 28,600 | 192,920 | Jul 29, 2021, 07:27 PM | |
| PRLD | Prelude Therapeutics Inc | Scherle Peggy | Chief Scientific Officer | Jul 27, 2021 | Sale | $35.47 | 20,000 | 709,380 | 173,600 | Jul 29, 2021, 07:27 PM | |
| PRLD | Prelude Therapeutics Inc | Scherle Peggy | Chief Scientific Officer | May 07, 2021 | Option Exercise | $1.43 | 10,000 | 14,300 | 182,920 | May 11, 2021, 06:46 PM | |
| PRLD | Prelude Therapeutics Inc | Scherle Peggy | Chief Scientific Officer | May 07, 2021 | Sale | $40.82 | 10,000 | 408,192 | 178,956 | May 11, 2021, 06:46 PM | |
| PRLD | Prelude Therapeutics Inc | Scherle Peggy | Chief Scientific Officer | Apr 07, 2021 | Option Exercise | $1.43 | 15,370 | 21,979 | 188,290 | Apr 09, 2021, 05:55 PM | |
| PRLD | Prelude Therapeutics Inc | Scherle Peggy | Chief Scientific Officer | Apr 07, 2021 | Sale | $39.31 | 15,370 | 604,144 | 180,001 | Apr 09, 2021, 05:55 PM |
Menu